An FDA-cleared wrist-worn device reliably detects convulsive seizures in epilepsy monitoring units but can miss focal ...
Use of GLP-1s is linked to lower risk for subarachnoid hemorrhage and mortality in patients with intracranial aneurysms and type 2 diabetes compared to use of other agents, a new study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results